104 related articles for article (PubMed ID: 10089044)
21. Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein.
Sällberg M; Zhang ZX; Chen M; Jin L; Birkett A; Peterson DL; Milich DR
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2721-8. PubMed ID: 8922465
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ
Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695
[TBL] [Abstract][Full Text] [Related]
23. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
[TBL] [Abstract][Full Text] [Related]
24. [Establishment of hybridomas secreting monoclonal antibodies to HIV-gp41 and HCV-NS3].
Zhang S; Pi G; Gu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):128-9. PubMed ID: 12569777
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies against NS3 and NS5 proteins of Japanese encephalitis virus.
Chen Z; Shao L; Ye J; Li Y; Huang S; Chen H; Cao S
Hybridoma (Larchmt); 2012 Apr; 31(2):137-41. PubMed ID: 22509919
[TBL] [Abstract][Full Text] [Related]
26. Humoral immune response to recombinant viral NS3 protein in patients with hepatitis C.
Gudim EA; Agapov II; Komolov IS; Tonevitskii AG
Bull Exp Biol Med; 2005 Jan; 139(1):77-80. PubMed ID: 16142283
[TBL] [Abstract][Full Text] [Related]
27. Production and characterization of a human monoclonal antibody to the hepatitis C virus NS4 region.
Mondelli MU; Cerino A; Bellotti V; de Lalla C; Rosa C; Bonelli F; Habets W
Year Immunol; 1993; 7():220-6. PubMed ID: 8396822
[No Abstract] [Full Text] [Related]
28. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines.
Wölk B; Sansonno D; Kräusslich HG; Dammacco F; Rice CM; Blum HE; Moradpour D
J Virol; 2000 Mar; 74(5):2293-304. PubMed ID: 10666260
[TBL] [Abstract][Full Text] [Related]
30. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
[TBL] [Abstract][Full Text] [Related]
31. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
32. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
33. DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus.
Isaguliants MG; Petrakova NV; Mokhonov VV; Pokrovskaya K; Suzdaltzeva YG; Krivonos AV; Zaberezhny AD; Garaev MM; Smirnov VD; Nordenfelt E
Immunol Lett; 2003 Jul; 88(1):1-13. PubMed ID: 12853154
[TBL] [Abstract][Full Text] [Related]
34. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
[TBL] [Abstract][Full Text] [Related]
35. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
[TBL] [Abstract][Full Text] [Related]
36. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice.
Takei S; Omoto C; Kitagawa K; Morishita N; Katayama T; Shigemura K; Fujisawa M; Kawabata M; Hotta H; Shirakawa T
Vaccine; 2014 May; 32(25):3066-74. PubMed ID: 24657718
[TBL] [Abstract][Full Text] [Related]
37. Characterization and application of monoclonal antibody against hepatitis C virus nonstructual protein three.
Shi H; Xie L; Shi H; Yan L; Duan Z
Hybridoma (Larchmt); 2012 Feb; 31(1):54-9. PubMed ID: 22316486
[TBL] [Abstract][Full Text] [Related]
38. [Preparation and properties of monoclonal antibodies to tick-borne encephalitis viral nonstructural proteins].
Matveeva VA; Dobrikova EIu; Tsekhanovskaia NA; Popova RV; Pressman EK; Karavanov AS; Matveev LE
Vopr Virusol; 1998; 43(3):134-7. PubMed ID: 9702814
[TBL] [Abstract][Full Text] [Related]
39. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
[TBL] [Abstract][Full Text] [Related]
40. Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
Ti J; Li Z; Li X; Lu Y; Diao Y; Li F
PLoS One; 2017; 12(7):e0181177. PubMed ID: 28746401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
